Morgan Stanley initiated coverage and assigned ratings to Recursion Pharmaceuticals, Absci, and Schrodinger, while Recursion maintained partnerships with Sanofi and Bayer.
3 reports, 1 independent
Updated Aug 10
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley initiated coverage and assigned ratings to Recursion Pharmaceuticals, Absci, and Schrodinger, while Recursion maintained partnerships with Sanofi and Bayer.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
company in Milan, Italy
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
-
BAYER
company in Prague, Czechia
-
Recursion (United States)
company in Salt Lake City, United States
Related events
Coverage
Newest first; wire copies grouped- insidermonkey.com
- Unknown outlet